These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37610280)

  • 1. Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post-hoc analysis of a prospective and multicenter study.
    Manosroi W; Phimphilai M; Waisayanand N; Buranapin S; Deerochanawong C; Gunaparn S; Phrommintikul A; Wongcharoen W;
    J Diabetes Investig; 2023 Dec; 14(12):1391-1400. PubMed ID: 37610280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the longitudinal trajectory of urinary albumin/creatinine ratio in diabetic patients with adverse cardiac event risk: a retrospective cohort study.
    Li H; Ren Y; Duan Y; Li P; Bian Y
    Front Endocrinol (Lausanne); 2024; 15():1355149. PubMed ID: 38745945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study.
    Song C; Yuan S; Cui K; Cai Z; Zhang R; He J; Qiao Z; Bian X; Wu S; Wang H; Shi B; Lin Z; Fu R; Wang C; Liu Q; Jia L; Dong Q; Dou K
    Cardiovasc Diabetol; 2023 Mar; 22(1):68. PubMed ID: 36966299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic effect of prediabetes defined by different criteria in patients with stable coronary artery disease: a prospective cohort study in Asia.
    Cui K; Yin D; Song W; Wang H; Zhu C; Feng L; Li J; Jia L; Lu Y; Zhang R; Shi B; Song Y; Fu R; Dou K
    Eur J Prev Cardiol; 2023 Oct; 30(14):1418-1426. PubMed ID: 36987575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Long-Term Visit-to-Visit Hemoglobin A1c and Cardiovascular Risk in Type 2 Diabetes: The ACCORD Trial.
    Huang D; Huang YQ; Zhang QY; Cui Y; Mu TY; Huang Y
    Front Cardiovasc Med; 2021; 8():777233. PubMed ID: 34901237
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
    Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes.
    Wang T; Lu J; Su Q; Chen Y; Bi Y; Mu Y; Chen L; Hu R; Tang X; Yu X; Li M; Xu M; Xu Y; Zhao Z; Yan L; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Shi L; Ning G; Zhao J; Wang W;
    JAMA Cardiol; 2019 Sep; 4(9):874-883. PubMed ID: 31365039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
    Bots SH; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle JL; Visseren FL; Westerink J;
    Cardiovasc Diabetol; 2016 Jul; 15(1):101. PubMed ID: 27431507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factor variability and cardiovascular risk among patients with diabetes: a nationwide observational study.
    Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Gudbjörnsdottir S; Eliasson B; Nicolucci A
    Eur J Prev Cardiol; 2023 Jun; 30(8):719-727. PubMed ID: 36897149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediabetes as a risk factor for major adverse cardiovascular events.
    Mando R; Waheed M; Michel A; Karabon P; Halalau A
    Ann Med; 2021 Dec; 53(1):2090-2098. PubMed ID: 34761971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visit-to-Visit Variability of Hemoglobin A
    Ghouse J; Skov MW; Kanters JK; Lind B; Isaksen JL; Blanche P; Haunsø S; Køber L; Svendsen JH; Olesen MS; Holst AG; Gerds TA; Nielsen JB
    Diabetes Care; 2019 Jan; 42(1):134-141. PubMed ID: 30352898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease.
    Yoo JH; Kang M; Kim G; Hur KY; Kim JH; Sinn DH; Jin SM
    J Diabetes Investig; 2021 Jul; 12(7):1252-1262. PubMed ID: 33135331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
    Cavender MA; Scirica BM; Raz I; Steg PG; McGuire DK; Leiter LA; Hirshberg B; Davidson J; Cahn A; Mosenzon O; Im K; Braunwald E; Bhatt DL
    Am J Med; 2016 Mar; 129(3):340.e1-8. PubMed ID: 26524706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.
    McAlister FA; Zheng Y; Westerhout CM; Buse JB; Standl E; McGuire DK; Van de Werf F; Green JB; Armstrong PW; Holman RR;
    Eur J Heart Fail; 2020 Nov; 22(11):2026-2034. PubMed ID: 32621557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediabetes increases the risk of major limb and cardiovascular events.
    Hsu JC; Yang YY; Chuang SL; Lee JK; Lin LY
    Cardiovasc Diabetol; 2023 Dec; 22(1):348. PubMed ID: 38115080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Hemoglobin A1c and Major Adverse Coronary Events in Patients with Diabetes Following Coronary Artery Bypass Surgery.
    Turgeon RD; Koshman SL; Youngson E; Pearson GJ
    Pharmacotherapy; 2020 Feb; 40(2):116-124. PubMed ID: 31883378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes.
    Sun B; He F; Gao Y; Zhou J; Sun L; Liu R; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jun; 64(3):536-543. PubMed ID: 30868413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target.
    Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Svensson AM; Eliasson B; Nicolucci A
    Cardiovasc Diabetol; 2022 Jan; 21(1):13. PubMed ID: 35073913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control.
    Hsu CP; Hsu PF; Chung MY; Lin SJ; Lu TM
    Cardiovasc Diabetol; 2014 Dec; 13():156. PubMed ID: 25467091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.